Translational control of the undifferentiated phenotype in ER‑positive breast tumor cells: Cytoplasmic localization of ERα and impact of IRES inhibition

Vaklavas,Christos; Zinn,Kurt R.; Samuel,Sharon L.; Meng,Zheng; Grizzle,William E.; Choi,Hyoungsoo; Blume,Scott W.

doi:10.3892/or.2018.6332

Translational control of the undifferentiated phenotype in ER‑positive breast tumor cells: Cytoplasmic localization of ERα and impact of IRES inhibition

Authors:
- Christos Vaklavas
- Kurt R. Zinn
- Sharon L. Samuel
- Zheng Meng
- William E. Grizzle
- Hyoungsoo Choi
- Scott W. Blume
View Affiliations

Affiliations: Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA
Published online on: March 23, 2018 https://doi.org/10.3892/or.2018.6332
Pages: 2482-2498
Copyright: © Vaklavas et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Using a series of potential biomarkers relevant to mechanisms of protein synthesis, we observed that estrogen receptor (ER)-positive breast tumor cells exist in two distinct yet interconvertible phenotypic states (of roughly equal proportion) which differ in the degree of differentiation and use of IRES-mediated translation. Nascently translated IGF1R in the cytoplasm positively correlated with IRES activity and the undifferentiated phenotype, while epitope accessibility of RACK1, an integral component of the 40S ribosomal subunit, aligned with the more differentiated IRES-off state. When deprived of soluble growth factors, the entire tumor cell population shifted to the undifferentiated phenotype in which IRES-mediated translation was active, facilitating survival under these adverse microenvironmental conditions. However, if IRES-mediated translation was inhibited, the cells instead were forced to transition uniformly to the more differentiated state. Notably, cytoplasmic localization of estrogen receptor α (ERα/ESR1) precisely mirrored the pattern observed with nascent IGF1R, correlating with the undifferentiated IRES-active phenotype. Inhibition of IRES-mediated translation resulted in both a shift in ERα to the nucleus (consistent with differentiation) and a marked decrease in ERα abundance (consistent with the inhibition of ERα synthesis via its IRES). Although breast tumor cells tolerated forced differentiation without extensive loss of their viability, their reproductive capacity was severely compromised. In addition, CDK1 was decreased, connexin 43 eliminated and Myc translation altered as a consequence of IRES inhibition. Isolated or low-density ER-positive breast tumor cells were particularly vulnerable to IRES inhibition, losing the ability to generate viable cohesive colonies, or undergoing massive cell death. Collectively, these results provide further evidence for the integral relationship between IRES-mediated translation and the undifferentiated phenotype and demonstrate how therapeutic manipulation of this specialized mode of protein synthesis may be used to limit the phenotypic plasticity and incapacitate or eliminate these otherwise highly resilient breast tumor cells.

View Figures

View References

1	Prats AC and Prats H: Translational control of gene expression: Role of IRESs and consequences for cell transformation and angiogenesis. Prog Nucleic Acid Res Mol Biol. 72:367–413. 2002. View Article : Google Scholar : PubMed/NCBI
2	Baird SD, Turcotte M, Korneluk RG and Holcik M: Searching for IRES. RNA. 12:1755–1785. 2006. View Article : Google Scholar : PubMed/NCBI
3	Spriggs KA, Stoneley M, Bushell M and Willis AE: Re-programming of translation following cell stress allows IRES-mediated translation to predominate. Biol Cell. 100:27–38. 2008. View Article : Google Scholar : PubMed/NCBI
4	Meng Z, Jackson NL, Choi H, King PH, Emanuel PD and Blume SW: Alterations in RNA-binding activities of IRES-regulatory proteins as a mechanism for physiological variability and pathological dysregulation of IGF-IR translational control in human breast tumor cells. J Cell Physiol. 217:172–183. 2008. View Article : Google Scholar : PubMed/NCBI
5	Nagamachi A, Htun PW, Ma F, Miyazaki K, Yamasaki N, Kanno M, Inaba T, Honda Z, Okuda T, Oda H, et al: A 5′untranslated region containing the IRES element in the Runx1 gene is required for angiogenesis, hematopoiesis and leukemogenesis in a knock-in mouse model. Dev Biol. 345:226–236. 2010. View Article : Google Scholar : PubMed/NCBI
6	Blau L, Knirsh R, Ben-Dror I, Oren S, Kuphal S, Hau P, Proescholdt M, Bosserhoff AK and Vardimon L: Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation. Proc Natl Acad Sci USA. 109:E2875–E2884. 2012. View Article : Google Scholar : PubMed/NCBI
7	Dobson T, Chen J and Krushel LA: Dysregulating IRES-dependent translation contributes to over-expression of the Aurora A kinase onco-protein. Mol Cancer Res. 11:887–900. 2013. View Article : Google Scholar : PubMed/NCBI
8	Lynch SR and Puglisi JD: Structural origins of aminoglycoside specificity for prokaryotic ribosomes. J Mol Biol. 306:1037–1058. 2001. View Article : Google Scholar : PubMed/NCBI
9	Hansen JL, Moore PB and Steitz TA: Structures of five antibiotics bound to the peptidyl transferase center of the large ribosomal subunit. J Mol Biol. 330:1061–1075. 2003. View Article : Google Scholar : PubMed/NCBI
10	Baselga J, Campone M, Piccart M, Burris HA III, Rugo HS, Sahmoud T, Noguchi S, Gnant M, Pritchard KI, Lebrun F, et al: Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N Engl J Med. 366:520–529. 2012. View Article : Google Scholar : PubMed/NCBI
11	Vaklavas C, Meng Z, Choi H, Grizzle WE, Zinn KR and Blume SW: Small molecule inhibitors of IRES-mediated translation. Cancer Biol Ther. 16:1471–1485. 2015. View Article : Google Scholar : PubMed/NCBI
12	Vaklavas C, Grizzle WE, Choi H, Meng Z, Zinn KR, Shrestha K and Blume SW: IRES inhibition induces terminal differentiation and synchronized death in triple-negative breast cancer and glioblastoma cells. Tumour Biol. 37:13247–13264. 2016. View Article : Google Scholar : PubMed/NCBI
13	Sengupta J, Nilsson J, Gursky R, Spahn CM, Nissen P and Frank J: Identification of the versatile scaffold protein RACK1 on the eukaryotic ribosome by cryo-EM. Nat Struct Mol Biol. 11:957–962. 2004. View Article : Google Scholar : PubMed/NCBI
14	Majzoub K, Hafirassou ML, Meignin C, Goto A, Marzi S, Fedorova A, Verdier Y, Vinh J, Hoffmann JA, Martin F, et al: RACK1 controls IRES-mediated translation of viruses. Cell. 159:1086–1095. 2014. View Article : Google Scholar : PubMed/NCBI
15	Barraille P, Chinestra P, Bayard F and Faye JC: Alternative initiation of translation accounts for a 67/45 kDa dimorphism of the human estrogen receptor ERalpha. Biochem Biophys Res Commun. 257:84–88. 1999. View Article : Google Scholar : PubMed/NCBI
16	Vedrenne C, Klopfenstein DR and Hauri HP: Phosphorylation controls CLIMP-63-mediated anchoring of the endoplasmic reticulum to microtubules. Mol Biol Cell. 16:1928–1937. 2005. View Article : Google Scholar : PubMed/NCBI
17	Nikonov AV, Hauri HP, Lauring B and Kreibich G: Climp-63-mediated binding of microtubules to the ER affects the lateral mobility of translocon complexes. J Cell Sci. 120:2248–2258. 2007. View Article : Google Scholar : PubMed/NCBI
18	Schiavi A, Hudder A and Werner R: Connexin43 mRNA contains a functional internal ribosome entry site. FEBS Lett. 464:118–122. 1999. View Article : Google Scholar : PubMed/NCBI
19	Marash L, Liberman N, Henis-Korenblit S, Sivan G, Reem E, Elroy-Stein O and Kimchi A: DAP5 promotes cap-independent translation of Bcl-2 and CDK1 to facilitate cell survival during mitosis. Mol Cell. 30:447–459. 2008. View Article : Google Scholar : PubMed/NCBI
20	Spandidos DA, Pintzas A, Kakkanas A, Yiagnisis M, Mahera H, Patra E and Agnantis NJ: Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue. Anticancer Res. 7:1299–1304. 1987.PubMed/NCBI
21	Hann SR, Dixit M, Sears RC and Sealy L: The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. Genes Dev. 8:2441–2452. 1994. View Article : Google Scholar : PubMed/NCBI
22	Benassayag C, Montero L, Colombié N, Gallant P, Cribbs D and Morello D: Human c-Myc isoforms differentially regulate cell growth and apoptosis in Drosophila melanogaster. Mol Cell Biol. 25:9897–9909. 2005. View Article : Google Scholar : PubMed/NCBI
23	Tecalco-Cruz AC, Pérez-Alvarado IA, Ramírez-Jarquín JO and Rocha-Zavaleta L: Nucleo-cytoplasmic transport of estrogen receptor alpha in breast cancer cells. Cell Signal. 34:121–132. 2017. View Article : Google Scholar : PubMed/NCBI
24	Lombardi M, Castoria G, Migliaccio A, Barone MV, Di Stasio R, Ciociola A, Bottero D, Yamaguchi H, Appella E and Auricchio F: Hormone-dependent nuclear export of estradiol receptor and DNA synthesis in breast cancer cells. J Cell Biol. 182:327–340. 2008. View Article : Google Scholar : PubMed/NCBI
25	Basak P, Chatterjee S, Weger S, Bruce MC, Murphy LC and Raouf A: Estrogen regulates luminal progenitor cell differentiation through H19 gene expression. Endocr Relat Cancer. 22:505–517. 2015. View Article : Google Scholar : PubMed/NCBI
26	Fan P, Wang J, Santen RJ and Yue W: Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells. Cancer Res. 67:1352–1360. 2007. View Article : Google Scholar : PubMed/NCBI
27	Guest SK, Ribas R, Pancholi S, Nikitorowicz-Buniak J, Simigdala N, Dowsett M, Johnston SR and Martin LA: Src is a potential therapeutic target in endocrine-resistant breast cancer exhibiting low estrogen Receptor-mediated transactivation. PLoS One. 11:e01573972016. View Article : Google Scholar : PubMed/NCBI
28	Dhamad AE, Zhou Z, Zhou J and Du Y: Systematic proteomic identification of the heat shock proteins (Hsp) that interact with estrogen receptor alpha (ERα) and biochemical characterization of the ERα-Hsp70 interaction. PLoS One. 11:e01603122016. View Article : Google Scholar : PubMed/NCBI
29	Yang HW, Kim TM, Song SS, Menon L, Jiang X, Huang W, Black PM, Park PJ, Carroll RS and Johnson MD: A small subunit processome protein promotes cancer by altering translation. Oncogene. 34:4471–4481. 2015. View Article : Google Scholar : PubMed/NCBI
30	Ruan Y, Sun L, Hao Y, Wang L, Xu J, Zhang W, Xie J, Guo L, Zhou L, Yun X, et al: Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma. J Clin Invest. 122:2554–2566. 2012. View Article : Google Scholar : PubMed/NCBI
31	Osman AM and van Loveren H: Matrin 3 co-immunoprecipitates with the heat shock proteins glucose-regulated protein 78 (GRP78), GRP75 and glutathione S-transferase π isoform 2 (GSTπ2) in thymoma cells. Biochimie. 101:208–214. 2014. View Article : Google Scholar : PubMed/NCBI
32	Gottardi CJ, Arpin M, Fanning AS and Louvard D: The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Proc Natl Acad Sci USA. 93:10779–10784. 1996. View Article : Google Scholar : PubMed/NCBI
33	Balda MS, Garrett MD and Matter K: The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol. 160:423–432. 2003. View Article : Google Scholar : PubMed/NCBI
34	Clarke R, Tyson JJ and Dixon JM: Endocrine resistance in breast cancer-An overview and update. Mol Cell Endocrinol. 418:220–234. 2015. View Article : Google Scholar : PubMed/NCBI
35	Murphy CG and Dickler MN: Endocrine resistance in hormone-responsive breast cancer: Mechanisms and therapeutic strategies. Endocr Relat Cancer. 23:R337–R352. 2016. View Article : Google Scholar : PubMed/NCBI